| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.4674 (Miss by $-0.0826) |
| EPS GAAP Actual | $0.4674 (Miss by $-0.0826) |
| Revenue Actual | $3.688B |
| Revenue Surprise | Beat by $3688M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.25884 |
| EPS GAAP Estimate | $1.25884 |
| Revenue Estimate | $4.00385159B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2029 | 0 | INF | 0 | 0 | 0 |
| Sep 2028 | 9.5 | 2.07 | 9.3351 | 9.68483 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.22 | -1.01943 | 3.688B | 3.42% | -472.11M |
| FQ2 2025 (Jun 2025) | 0.43 | -0.78952 | 3.741B | 0.67% | -382.46M |
| FQ1 2025 (Mar 2025) | -3.99 | -4.72454 | 3.611B | -3.85% | -280.83M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 3.495B | -4.72% | 3495M |
| FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 3.562B | 100% | 3562M |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 3.716B | -9.12% | 3716M |
| FQ1 2024 (Mar 2024) | -0.77 | -0.77 | 3.75B | -4.32% | 3750M |
| FQ4 2023 (Dec 2023) | 0.48 | 0.48 | 3.66B | -1.07% | 3660M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.25884
Consensus Revenue Estimates
4.00385159B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 1.06 | -- | 1.03563 | 1.09264 | 1 |
| FQ1 2027 (Mar 2027) | 0.77 | -- | 0.7523 | 0.79371 | 1 |
| FQ4 2026 (Oct 2026) | 1.38 | -- | 1.36649 | 1.39247 | 3 |
| FQ3 2026 (Jul 2026) | 1.42 | 84.51 | 1.4061 | 1.43283 | 3 |
| FQ2 2026 (Jun 2026) | 1.42 | 69.72 | 1.37569 | 1.44639 | 3 |
| FQ1 2026 (Mar 2026) | 0.56 | 812.5 | 0.54253 | 0.57041 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 3.68B | -- | 3.62B | 3.77B | 2 |
| FQ1 2027 (Mar 2027) | 3.61B | -- | 3.54B | 3.69B | 2 |
| FQ4 2026 (Oct 2026) | 4.14B | -- | 4.11B | 4.17B | 2 |
| FQ3 2026 (Jul 2026) | 4.23B | 12.91 | 4.2B | 4.26B | 2 |
| FQ2 2026 (Jun 2026) | 4.28B | 12.53 | 4.17B | 4.34B | 2 |
| FQ1 2026 (Mar 2026) | 3.94B | 8.35 | 3.85B | 4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.23943 | 0.22 | -1.01943 | -463.38% |
| FQ2 2025 (Jun 2025) | 1.21952 | 0.43 | -0.78952 | -183.61% |
| FQ1 2025 (Mar 2025) | 0.73454 | -3.99 | -4.72454 | 118.41% |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 100% | |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 100% | |
| FQ1 2024 (Mar 2024) | -0.77 | -0.77 | 100% | |
| FQ4 2023 (Dec 2023) | 0.48 | 0.48 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $4.16B | $3.69B | $-472.11M | -12.8% |
| FQ2 2025 (Jun 2025) | $4.12B | $3.74B | $-382.46M | -10.22% |
| FQ1 2025 (Mar 2025) | $3.89B | $3.61B | $-280.83M | -7.78% |
| FQ4 2024 (Dec 2024) | $0B | $3.5B | $3495M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.56B | $3562M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.72B | $3716M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.75B | $3750M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.66B | $3660M | 100% |